Trial by Dutch laboratories for evaluation of non‐invasive prenatal testing. Part I—clinical impact
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To evaluate the clinical impact of nationwide implementation of genome-wide non-invasive prenatal testing (NIPT) in pregnancies at increased risk for fetal trisomies 21, 18 and 13 (TRIDENT study). METHOD: Women with elevated risk based on first trimester combined testing (FCT ≥ 1:200) or medical history, not advanced maternal age alone, were offered NIPT as contingent screening test, performed by Dutch University Medical laboratories. We analyzed uptake, test performance, redraw/failure rate, turn-around time and pregnancy outcome. RESULTS: Between 1 April and 1 September 2014, 1413/23 232 (6%) women received a high-risk FCT result. Of these, 1211 (85.7%) chose NIPT. One hundred seventy-nine women had NIPT based on medical history. In total, 1386/1390 (99.7%) women received a result, 6 (0.4%) after redraw. Mean turn-around time was 14 days. Follow-up was available in 1376 (99.0%) pregnancies. NIPT correctly predicted 37/38 (97.4%) trisomies 21, 18 or 13 (29/30, 4/4 and 4/4 respectively); 5/1376 (0.4%) cases proved to be false positives: trisomies 21 (n = 2), 18 (n = 1) and 13 (n = 2). Estimated reduction in invasive testing was 62%. CONCLUSION: Introduction of NIPT in the Dutch National healthcare-funded Prenatal Screening Program resulted in high uptake and a vast reduction of invasive testing. Our study supports offering NIPT to pregnant women at increased risk for fetal trisomy. © 2016 The Authors. Prenatal Diagnosis published by John Wiley & Sons, Ltd. © 2016 The Authors. Prenatal Diagnosis published by John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cell-free DNA Analysis for Noninvasive Examination of Trisomy
Norton, M. E., Jacobsson, B., Swamy, G. K., Laurent, L. C., Ranzini, A. C., Brar, H., Tomlinson, M. W., Pereira, L., Spitz, J. L., Hollemon, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1407349 · Cited by 817
Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review
Green, J., Hewison, J., Bekker, H., Bryant, L., & Cuckle, H. (2004) · Health Technology Assessment · doi:10.3310/hta8330 · Cited by 368 · cited 1×
“Fear for invasive testing makes many of these women refrain from further testing, and some even refrain from screening.(5,6)”
Cited by
Analysis of cell-free DNA in maternal blood in screening for aneuploidies: Updated meta-analysis
Gil, M. M., Accurti, V., Santacruz, B., Plana, M. N., & Nicolaides, K. H. (2017) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.17484 · Cited by 683
van der Meij, K. R. M., Sistermans, E. A., Macville, M. V. E., Stevens, S. J. C., Bax, C. J., Bekker, M. N., Bilardo, C. M., Boon, E. M. J., Boter, M., Diderich, K. E. M., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.10.005 · Cited by 372
Self-citationSequencing of Circulating Cell-free DNA during Pregnancy
Bianchi, D. W., & Chiu, R. W. K. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1705345 · Cited by 313
van Schendel, R. V., Page‐Christiaens, G. C. M. L., Beulen, L., Bilardo, C. M., de Boer, M. A., Coumans, A. B. C., Faas, B. H. W., van Langen, I. M., Lichtenbelt, K. D., van Maarle, M. C., et al. (2017) · Journal of Genetic Counseling · doi:10.1007/s10897-017-0118-3 · Cited by 59
“Here we studied Dutch high-risk women who were offered NIPT as an alternative to invasive testing within the nationwide TRIDENT study (Trial by Dutch laboratories for Evaluation of Non-Invasive Prenatal Testing) (Oepkes et al. 2016).”
BackgroundMethodInfluentialSelf-citation
Metadata
- Authors
- Oepkes, D., Page‐Christiaens, G. C. (., Bax, C. J., Bekker, M. N., Bilardo, C. M., Boon, E. M. J., Schuring‐Blom, G. H., Coumans, A. B. C., Faas, B. H., Galjaard, R. H., Go, A. T., Henneman, L., Macville, M. V. E., Pajkrt, E., Suijkerbuijk, R. F., Huijsdens‐van Amsterdam, K., Van Opstal, D., Verweij, E. J. (., Weiss, M. M., Sistermans, E. A., & and for the Dutch NIPT Consortium
- Venue
- Prenatal Diagnosis
- Publisher
- Wiley
- Published
- 2016-11-15
- Volume
- 36
- Issue
- 12
- Pages
- 1083-1090
- ISSN
- 0197-3851 (ISSN-L)
- 1097-0223
- OpenAlex
- W2538950255
- Cited by
- 149
- References
- 2
- FWCI
- 21.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Trial by Dutch laboratories for evaluation of non‐invasive prenatal testing. Part I—clinical impact. https://app.cochat.ai/papers/10.1002/pd.4945
- The paper
- Oepkes, D., Page‐Christiaens, G. C. (., Bax, C. J., Bekker, M. N., Bilardo, C. M., Boon, E. M. J., Schuring‐Blom, G. H., Coumans, A. B. C., Faas, B. H., Galjaard, R. H., Go, A. T., Henneman, L., Macville, M. V. E., Pajkrt, E., Suijkerbuijk, R. F., Huijsdens‐van Amsterdam, K., Van Opstal, D., Verweij, E. J. (., Weiss, M. M., . . . and for the Dutch NIPT Consortium. (2016). Trial by Dutch laboratories for evaluation of non‐invasive prenatal testing. Part I—clinical impact. Prenatal Diagnosis. https://doi.org/10.1002/pd.4945
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.